148 related articles for article (PubMed ID: 24642424)
1. Gold nanoparticle-based immuno-PCR for detection of tau protein in cerebrospinal fluid.
Stegurová L; Dráberová E; Bartos A; Dráber P; Rípová D; Dráber P
J Immunol Methods; 2014 Apr; 406():137-42. PubMed ID: 24642424
[TBL] [Abstract][Full Text] [Related]
2. Rapid and sensitive detection of cytokines using functionalized gold nanoparticle-based immuno-PCR, comparison with immuno-PCR and ELISA.
Potůčková L; Franko F; Bambousková M; Dráber P
J Immunol Methods; 2011 Aug; 371(1-2):38-47. PubMed ID: 21704628
[TBL] [Abstract][Full Text] [Related]
3. Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.
Yamamori H; Khatoon S; Grundke-Iqbal I; Blennow K; Ewers M; Hampel H; Iqbal K
Neurosci Lett; 2007 May; 418(2):186-9. PubMed ID: 17400380
[TBL] [Abstract][Full Text] [Related]
4. [The measurement of phosphorylated tau in human cerebrospinal fluid as a diagnostic marker for Alzheimer's disease].
Urakami K; Ito N; Arai H; Ishiguro K; Ohno H; Nakashima K
Seishin Shinkeigaku Zasshi; 2003; 105(4):393-7. PubMed ID: 12806900
[TBL] [Abstract][Full Text] [Related]
5. Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer's disease.
Singer D; Soininen H; Alafuzoff I; Hoffmann R
Anal Bioanal Chem; 2009 Dec; 395(7):2263-7. PubMed ID: 19821112
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol.
Herbert MK; Kuiperij HB; Verbeek MM
J Immunol Methods; 2012 Jul; 381(1-2):1-8. PubMed ID: 22542401
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
8. The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms.
O'Dowd ST; Ardah MT; Johansson P; Lomakin A; Benedek GB; Roberts KA; Cummins G; El Agnaf OM; Svensson J; Zetterberg H; Lynch T; Walsh DM
J Alzheimers Dis; 2013; 33(4):923-8. PubMed ID: 23034520
[TBL] [Abstract][Full Text] [Related]
9. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.
Nishimura T; Takeda M; Nakamura Y; Yosbida Y; Arai H; Sasaki H; Shouji M; Hirai S; Khise K; Tanaka K; Hamamoto M; Yamamoto H; Matsubayashi T; Urakami K; Adachi Y; Nakashima K; Toji H; Nakamura S; Yoshida H
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):227-35. PubMed ID: 9646285
[TBL] [Abstract][Full Text] [Related]
10. Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
Jongbloed W; Kester MI; van der Flier WM; Veerhuis R; Scheltens P; Blankenstein MA; Teunissen CE
Alzheimers Dement; 2013 May; 9(3):276-83. PubMed ID: 23110867
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid.
Schipke CG; Prokop S; Heppner FL; Heuser I; Peters O
Dement Geriatr Cogn Disord; 2011; 31(2):139-45. PubMed ID: 21304219
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
[TBL] [Abstract][Full Text] [Related]
13. Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies.
Lachno DR; Romeo MJ; Siemers ER; Vanderstichele H; Coart E; Konrad RJ; Zajac JJ; Talbot JA; Jensen HF; Sethuraman G; Demattos RB; May PC; Dean RA
J Alzheimers Dis; 2011; 26(3):531-41. PubMed ID: 21694458
[TBL] [Abstract][Full Text] [Related]
14. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.
Barten DM; Cadelina GW; Hoque N; DeCarr LB; Guss VL; Yang L; Sankaranarayanan S; Wes PD; Flynn ME; Meredith JE; Ahlijanian MK; Albright CF
J Alzheimers Dis; 2011; 24 Suppl 2():127-41. PubMed ID: 21422517
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
Ibach B; Binder H; Dragon M; Poljansky S; Haen E; Schmitz E; Koch H; Putzhammer A; Kluenemann H; Wieland W; Hajak G
Neurobiol Aging; 2006 Sep; 27(9):1202-11. PubMed ID: 16085339
[TBL] [Abstract][Full Text] [Related]
16. Quantification of α-tubulin isotypes by sandwich ELISA with signal amplification through biotinyl-tyramide or immuno-PCR.
Dráberová E; Stegurová L; Sulimenko V; Hájková Z; Dráber P; Dráber P
J Immunol Methods; 2013 Sep; 395(1-2):63-70. PubMed ID: 23851142
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cerebrospinal fluid tau/beta-amyloid(42) ratio as diagnostic markers for Alzheimer disease.
Smach MA; Charfeddine B; Ben Othman L; Lammouchi T; Dridi H; Nafati S; Ltaief A; Bennamou S; Limem K
Eur Neurol; 2009; 62(6):349-55. PubMed ID: 19786779
[TBL] [Abstract][Full Text] [Related]
18. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
Mollenhauer B; Steinacker P; Bahn E; Bibl M; Brechlin P; Schlossmacher MG; Locascio JJ; Wiltfang J; Kretzschmar HA; Poser S; Trenkwalder C; Otto M
Neurodegener Dis; 2007; 4(5):366-75. PubMed ID: 17622779
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticle enhanced immuno-PCR for ultrasensitive detection of Hantaan virus nucleocapsid protein.
Chen L; Wei H; Guo Y; Cui Z; Zhang Z; Zhang XE
J Immunol Methods; 2009 Jul; 346(1-2):64-70. PubMed ID: 19467237
[TBL] [Abstract][Full Text] [Related]
20. [Alzheimer's disease as brain amyloidosis: diagnosis using cerebrospinal fluid abeta and tau].
Shoji M
Rinsho Byori; 2006 May; 54(5):503-8. PubMed ID: 16789421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
